The Silicon Valley billionaire thinks Palantir's growth story is just getting started.

The average COLA increase isn't anything to get too excited about, but some people will get a lot more in 2025.

Although CD rates are falling, they're still competitive. Here's why this writer is putting her money elsewhere.

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

The tech company recently split its shares on a 10-for-1 basis.

Natural gas demand is on track to grow sharply by 2030. The lower-carbon fuel is helping meet the accelerating demand for ...

Nvidia's stock has enjoyed incredible gains over the last five years. It's only natural for competitors to pop up.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In the second quarter, Hims & Hers Health reported revenue of around $316 million, up 52% from the year-ago period. It also ...

Summit Therapeutics (SMMT 7.20%) is an exciting stock for many investors as its shares are up by 158% in the last three ...

This year, some notable companies have cut or eliminated their dividends. For example, former stalwarts Walgreens and 3M ...

In mid-September, the Federal Reserve lowered its benchmark interest rate by half-a-percentage-point. And in the coming ...